Yohei Marukawa < Yohei Seto < Yohei Takano

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Yohei Seto

Number of relevant bibliographic references: 7.

Ident.	Authors (with country if any)	Title
001231 (2018)	Yoko Shimizu [Japon] ; Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Kumi Shidara [Japon] ; Naoki Sugimoto [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]	Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.
001726 (2017)	Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Rei Yamaguchi [Japon] ; Yoko Shimizu [Japon] ; Akiko Kobayashi [Japon] ; Naoki Sugimoto [Japon] ; Daisuke Hoshi [Japon] ; Kumi Shidara [Japon] ; Eri Sato [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]	Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.
002073 (2015)	Eiichi Tanaka [Japon] ; Eisuke Inoue ; Daisuke Hoshi ; Yoko Shimizu ; Akiko Kobayashi ; Naoki Sugimoto ; Kumi Shidara ; Eri Sato ; Yohei Seto ; Ayako Nakajima ; Shigeki Momohara ; Atsuo Taniguchi ; Hisashi Yamanaka	Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
002091 (2015)	Eri Sato [Japon] ; Eiichi Tanaka ; Moeko Ochiai ; Yoko Shimizu ; Akiko Kobayashi ; Kumi Shidara ; Daisuke Hoshi ; Naoki Sugimoto ; Eisuke Inoue ; Yohei Seto ; Ayako Nakajima ; Atsuo Taniguchi ; Shigeki Momohara ; Hisashi Yamanaka	Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
002785 (2013)	Daisuke Hoshi [Japon] ; Ayako Nakajima ; Kumi Shidara ; Yohei Seto ; Eiichi Tanaka ; Atsuo Taniguchi ; Shigeki Momohara ; Hisashi Yamanaka	Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.
002827 (2013)	Akito Takamura [Japon] ; Shintaro Hirata ; Hayato Nagasawa ; Hideto Kameda ; Yohei Seto ; Tatsuya Atsumi ; Makoto Dohi ; Takao Koike ; Nobuyuki Miyasaka ; Masayoshi Harigai	A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
003501 (2012)	Daisuke Hoshi [Japon] ; Ayako Nakajima ; Eisuke Inoue ; Kumi Shidara ; Eri Sato ; Mariko Kitahama ; Yohei Seto ; Eiichi Tanaka ; Wako Urano ; Naomi Ichikawa ; Yumi Koseki ; Shigeki Momohara ; Astuo Taniguchi ; Norihiro Nishimoto ; Hisashi Yamanaka	Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Yohei Seto" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Yohei Seto" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Yohei Seto
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021